September 9: VC Spotlight | Diabetes Diagnostics, Monitoring and Treatment
The prevalence of diabetes continues to grow, with nearly 8 percent of the U.S. population, or 23.6 million children and adults, who are living with the disease. According to the American Diabetes Association, nearly one third of the total economic cost of the disease – $174 billion – accounts for chronic diabetes-related complications. The increased percentage of people living with diabetes has led many Northern California life science companies to focus their development efforts on innovative treatments for the disease. This large and growing size of the patient population was not lost of the Northern California venture community with a number of Venture Capitalists and Angels investing heavily in diabetes diagnostics, monitoring and care. In a reverse pitch format a panel of investors will discuss their current interests, at what stage they are looking to invest, target markets and opportunities, therapies and technologies. Q&A and networking will provide an opportunity to better understand and form a successful relationship with investors. In Menlo Park+. Detailed Information.

September 9: Executive Reception with Jeremy Leffler Chief Operating Officer, BayBio
Attend an executive reception welcoming the newest addition to the BayBio team - Chief Operating Officer, Jeremy Leffler. No boring speeches, no official program - just an opportunity to connect for BayBio Board and BayBio Partners over a glass of wine and Hors d'oeuvres in a relaxed atmosphere. In San Francisco. Detailed Information.

September 15-16, 2010: California Industrial Biotech Conference
BIOCOM and BayBio are creating a day and a half conference that will combine the business, research and investment aspects for the industrial biotech community in this unique statewide conference. Through panel discussions, partnering opportunities and ample networking opportunities to extend your relationships. This conference will educate participants on the opportunities and challenges facing industrial biotech companies and ultimately demonstrate why California is a center of innovation in the industrial biotech space. At the Hard Rock Hotel- San Diego, CA. Detailed Information

September 30: CEO & CFO Roundtable | Prescription for Success: Managing Your Executive Team
In an ideal world, you pick your own executive team and it is productive, delivers high performance, fosters innovation and, most importantly, helps you to manage complex issues. Reality, of course, is different with a CEO frequently inheriting a team assembled by someone else with both high-performers as well as slightly less than high achievers abound. How do you play to the natural strengths of your executive team that lead to peak performance? How do you best manage your executive team dynamics? What are the best communication tools and techniques? How do you manage a conflict? At what point do you bring an executive coach? How and when do you make a decision to replace your senior executives? And, finally, how do you know that you are the most effective manager yourself? Join CEOs from leading life sciences companies for an interactive session, to hear their war stories, to discuss real life solutions and learn of the practices that produce best results. In Redwood City. Detailed Information.

October 6, 2010: BayBio Summer Blowout Mixer and Open House
Join BayBio for its End of Summer Blowout Mixer at the Pacific Research Center, immediately off of Highway 84 and the Dumbarton Bridge in Newark. Barbecue and ice cream set the stage for this entertaining networking reception. Meet BayBio staff and vendors to learn more about cost-saving tips and BayBio Business Solutions. Leave with detailed insight into how BayBio can help your organization succeed and lower its bottom line using BayBio Business Solutions. The Pacific Research Center is a 10-building multi-tenant campus with 1.4 million square feet of laboratory, R&D and office space. Tours of the campus and laboratory suites at the Pacific Research Center will be offered by its owner, BioMed Realty Trust. Detailed Information

October 21, 2010: BayBio Life Science Series Therapeutic Focus | Drug and Biomarker Developments: The Evolution of Blockbusters?
The promise of personalized medicine has begun to be realized with several commercially successful products, notably Herceptin, Gleevec, and Rituxan that all rival conventional "blockbusters." Higher rates of efficacy and more efficient (and therefore cost effective) trials have made products based on biomarkers increasingly intriguing and attractive to an industry chronically beset with R&D failures. Should we expect life science and pharma companies to embrace the biomarker strategy as their primary business model, or will biomarker-derived products remain a niche market? And should diagnostics be developed in tandem with pharmaceuticals or independently? A panel of experienced industry executives will focus on the real world experiences and will provide valuable insight into business and regulatory landscape surrounding biomarker technology. In South San Francisco. Detailed Information

November 4, 2010: BayBio Pantheon 2010 | Presenting DiNA Awards
Each year BayBio recognizes achievement and honors excellence in the life sciences industry in Northern California, as it brings together Northern California’s life sciences industry leaders. The Pantheon Awards Ceremony is a celebration of the contributions and achievements of the Bay Area, a moment in time to pause and reflect on the industry's legacy over three decades. In San Francisco. Detailed Information

November 4-5, 2010: BioBasics- 2 Day Class | Industry Knowledge for the Non-Scientist
Learn the basics of biotechnology by skilled and experienced industry scientists. Join other non-science professionals and gain a thorough understanding of the science, technology and terminology which form the foundation of the biotechnology industry. Detailed Information

January 27, 2011: BayBio Life Science Series VC Spotlight | Changing Biotech Business Models
A wave of generic drugs based on today’s top blockbusters, the expansion of personalized medicine, fundamental healthcare reform in the United States, and the continued globalization of the industry – on top of a global financial crisis – have made the standard biotech business model unsustainable. How can the industry change the ways in which drugs are developed and commercialized? What are the alternative business models? What is the goal (fail early and cheap)? And are investors driving change in behavior? A panel of seasoned investors – VCs, angels, and corporate investors – will reflect on investments made over the last two years and during the 2011 JP Morgan Healthcare Conference, highlighting what life science entrepreneurs should expect ahead. Q&A and networking will provide an opportunity to better understand and form a successful relationship with investors. In South San Francisco. Detailed Information

April 21-22, 2011: BayBio2011 Annual Conference | Powering Global Innovation
With Northern California regarded as a global innovation engine, the BayBio2011 Annual Conference will explore themes and topics that focus on fostering global collaborations in research, development and commercialization. The BayBio2011 Annual Conference is expanding into a two-day event and will attract more than 1,000 life science professionals from around the globe. In Burlingame. Detailed Information